Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
Clinical and Molecular Hepatology
; : 417-420, 2013.
Article
ي En
| WPRIM
| ID: wpr-34823
المكتبة المسؤولة:
WPRO
ABSTRACT
Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious complications such as myocardial infarction, skin necrosis, or bowel ischemia. Herein we report a case of severe ischemic bowel necrosis in a 46-year-old cirrhotic patient treated with terlipressin. Although the patient received bowel resection, death occurred due to ongoing hypotension and metabolic acidosis. Attention should be paid to patients complaining of abdominal pain during treatment with terlipressin.
Key words
النص الكامل:
1
الفهرس:
WPRIM
الموضوع الرئيسي:
Vasoconstrictor Agents
/
Bilirubin
/
Hepatorenal Syndrome
/
Lypressin
/
Tomography, X-Ray Computed
/
Fatal Outcome
/
Creatinine
/
Electrocardiography
/
Intestinal Mucosa
/
Intestines
المحددات:
Humans
/
Male
اللغة:
En
مجلة:
Clinical and Molecular Hepatology
السنة:
2013
نوع:
Article